6-Chloro-7-deazapurine-β-D-riboside

• CAT Number: R001665
• CAS Number: 16754-80-6
• Molecular Formula: C₁₁H₁₂ClN₃O₄
• Molecular Weight: 285.68
• Purity: ≥95%
• Synonyms: 4-chloro-7-β-D-ribofuranosyl-7H-Pyrrolo[2,3-d]pyrimidine; 4-Chloro-7-(β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine; 6-Chloro-9-(β-D-ribofuranosyl)-7-deazapurine; 6-Deamino-6-chlorotubercidin; NSC 101161
• Storage: -20°C
• IUPAC Name: (2R,3R,4S,5R)-2-(4-chloropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol
• InChI: InChI=1S/C11H12ClN3O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2/t6-,7-,8-,11-/m1/s1
• InChIKey: BFDDOTZWMOKUCD-KCGFPETGSA-N
• SMILES: C1=CN(C2=C1C(=NC=N2)Cl)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O

6-Chloro-7-deazapurine-β-D-riboside（Cat No.:R001665）is a purine nucleoside analog used in biochemical and pharmaceutical research. Featuring a 6-chloro substitution on the purine ring, this compound plays a role in nucleic acid synthesis and enzyme inhibition studies. It is commonly used in studies related to antiviral and anticancer therapies due to its ability to interfere with cellular metabolism and DNA/RNA functions. Its riboside form enhances its solubility and bioavailability, making it a useful tool in drug development and research into purine metabolism and nucleoside-based therapeutics.